Laura Tinti graduated in Chemistry and Pharmaceutical Technology from the University of Siena with an experimental thesis at the Department of Pharmacology and Toxicology of the University of Vienna. She then obtained her PhD in Biomedicine and Immunological Sciences at the University of Siena with a project focused on the development of new in vitro models for the study of a rare disease, Alkaptonuria. She also spent part of her training period abroad, at the Department of Human Anatomy and Cell Biology of the University of Liverpool and at the Faculty of Medicine of the University of Auckland, New Zealand. In 2010 she joined the Toscana Life Sciences Foundation as a researcher, where she began to follow a series of projects aimed at the treatment of several orphan diseases as part of a programme funded by the Region of Tuscany. In 2012 she won a Telethon grant focused on the development of an enzyme replacement therapy for methylmalonic aciduria with homocystinuria. To date, he is the contact person for proteomics services and for the development of new methods for evaluating the efficacy of botanical extracts.